Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desoximetasone Adherence in Resistant AD and Psoriasis
NCT03050294Phase 4Completed
- Sponsor
- Wake Forest University Health Sciences
- Start
- Feb 2017
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of desoximetasone in atopic dermatitis (AD), psoriasis, sponsored by Wake Forest University Health Sciences. Started Feb 2017; status: completed.
02
Drugs
desoximetasone
03
Conditions
atopic dermatitis (AD)psoriasis
Beyond the preview
Go deeper on NCT03050294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03050294.